Evaluation of Cardiomyocyte Proliferation after Transplantation of Engineered Heart Tissue Patches

Transplantation of engineered heart tissue (EHT) derived from human induced pluripotent stem cells (hiPSC) represents a promising regenerative strategy. Recent studies provided first evidence that hiPSC-derived cardiomyocytes re-enter the cell cycle after transplantation. The aim of this project was to analyze cardiomyocyte proliferation after transplantation in detail.

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: L. Castro, M. Reinsch, E. Querdel, B. Geertz, T. Eschenhagen, H. Reichenspurner, S. Pecha, F. Weinberger Tags: (423) Source Type: research